外科的治療法，補助療法

池永 直樹; 井岡 達也; 江口 英利; 大塚 隆生; 尾上 俊介; 川井 学; 庄 雅之; 杉浦 禎一; 仲田 興平; 中村 聡明; 藤井 努; 松本 逸平; 松山 隆生; 水間 正道; 山本 智久; 中村 雅史

doi:10.2958/suizo.38.115

Special Editions

Clinical Practice Guidelines for Pancreatic Cancer 2022 -revisions to surgical and adjuvant therapies-

Naoki IKENAGA, Tatsuya IOKA, Hidetoshi EGUCHI, Takao OHTSUKA, Shunsuke ONOE, Manabu KAWAI, Masayuki SHO, Teiichi SUGIURA, Kohei NAKATA, Satoaki NAKAMURA, Tsutomu FUJII, Ippei MATSUMOTO, Ryusei MATSUYAMA, Masamichi MIZUMA, Tomohisa YAMAMOTO, Masafumi NAKAMURA

Author information

Naoki IKENAGA
Department of Surgery and Oncology, Kyushu University
Tatsuya IOKA
Department of Oncology Center, Yamaguchi University Hospital
Hidetoshi EGUCHI
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University
Takao OHTSUKA
Department of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University
Shunsuke ONOE
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine
Manabu KAWAI
Second Department of Surgery, Wakayama Medical University
Masayuki SHO
Department of Surgery, Nara Medical University
Teiichi SUGIURA
Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center
Kohei NAKATA
Department of Surgery and Oncology, Kyushu University
Satoaki NAKAMURA
Division of Radiation Oncology, Kansai Medical University
Tsutomu FUJII
Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama
Ippei MATSUMOTO
Department of Surgery, Kindai University Faculty of Medicine
Ryusei MATSUYAMA
Department of Gastroenterological Surgery, Yokohama City University
Masamichi MIZUMA
Department of Surgery, Tohoku University
Tomohisa YAMAMOTO
Department of Surgery, Kansai Medical University
Masafumi NAKAMURA
Department of Surgery and Oncology, Kyushu University

Keywords: Pancreatic cancer, Guideline, Surgical therapy, Adjuvant therapy

JOURNAL FREE ACCESS

2023 Volume 38 Issue 2 Pages 115-120

DOI https://doi.org/10.2958/suizo.38.115

Details

Abstract

The Clinical Practice Guidelines for Pancreatic Cancer 2022 were newly revised in July 2022. Compared with the previous 2019 version, three clinical questions (CQs) were created, five CQs/statements were modified, and two CQs were abolished, resulting in 20 CQs inquiring about surgical and adjuvant therapies being established in the 2022 version. This article describes the revision to CQs and statements in surgical and adjuvant therapies of the Clinical Practice Guidelines for Pancreatic Cancer 2022.

Corresponding author

Register with J-STAGE for free!